Duyurular
Regulation on Market Control of Medicinal Products for Human Use has been Published
The Regulation on Market Control of Medicinal Products for Human Use has been recently published in the Official Gazette on June 1, 2023, with the reference number 32208. The main objective of this Regulation is to establish the procedures, principles, responsibilities, and authorities concerning market control activities conducted by the Turkish Medicines and Medical Devices Agency (referred to as the Agency) to ensure the availability of licensed/permitted medicinal products for human use and foods for special medical purposes with the desired efficacy, safety, and quality in the market.
Under this Regulation, the Agency will determine the inclusion of products and active substances in the market control program based on predefined risk parameters. Once the samples are submitted to the Agency, they will undergo thorough examination and analysis at the National Control Laboratory.
If the analysis results at the National Control Laboratories, as part of this Regulation, deem the products and active substances to be unsuitable, the necessary evaluations will be conducted according to the Withdrawal Regulation published in the Official Gazette on November 19, 2015, with the reference number 29537.
In cases where the Agency decides to withdraw a product in accordance with the Withdrawal Regulation, the license holder will receive a notification to initiate the required actions and procedures. The Agency will proceed according to the provisions stated in Law No. 1262.
Likewise, if the Agency decides to withdraw an active substance in line with the Withdrawal Regulation, the holder of the production site permit will be notified to carry out the necessary actions and procedures. The Authority will take appropriate measures in accordance with the provisions outlined in Law No. 1262.
Furthermore, if the Agency's warnings regarding faulty products resulting from market controls are disregarded, and the production of faulty products continues, appropriate actions will be taken in accordance with the regulations pertaining to the Licensing of Medicinal Products for Human Use, the Licensing of Traditional Herbal Medicinal Products, the Licensing of Homeopathic Medicinal Products, and the Licensing of Foods for Special Medical Purposes.
The Regulation came into effect on June 1, 2023, and the complete text of Law No. 1262 on Pharmaceutical and Medicinal Preparations can be found here.
The full text of the Regulation can be accessed here.
Kind regards,
Zumbul Attorneys-at-Law
Türkçe
English